Search results
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 1 day agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 5 days agoWhat are the symptoms associated with KP.3? ... or runny nose Nausea or vomiting Diarrhea A new ...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 1 day agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 21 hours agoModerna (NASDAQ:MRNA) stock has surged 40.8% since the turn of the year. Some of this momentum can...
Gateway - Quartz
Quartz· 8 hours agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an early-phase clinical trial testing the combined use of an experimental cancer ...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
New COVID Mystery? Those 'Excess Deaths'
newser· 2 days agoCOVID vaccines "were provided to guard civilians," but didn't always work as advertised. Clinical trials showed that Pfizer and Moderna vaccine ...
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 6 days agoModerna price target raised at Oppenheimer after RSV vaccine approval
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 6 days agoModerna will rival Pfizer and GSK, which launched their shots last year. Also, in June, Moderna and...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation...
NewMediaWire via Yahoo Finance· 6 hours ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
